Observational Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Sep 7, 2022; 28(33): 4861-4874
Published online Sep 7, 2022. doi: 10.3748/wjg.v28.i33.4861
Table 1 Demographic data for irritable bowel syndrome patients with abdominal pain alone, abdominal discomfort alone, and abdominal pain & discomfort
VariablePain group (n = 233)Discomfort group (n = 83)Pain & discomfort group (n = 51)P value
Male, %117 (50.2)56 (67.5)32 (62.7)0.012
Age in yr43.7 ± 11.742.3 ± 10.640.8 ± 11.00.23
BMI in kg/m223.0 ± 4.022.8 ± 4.022.3 ± 3.80.56
Education level, college and above, %71 (30.5)29 (34.9)13 (25.5)0.51
Physical labor, %135 (57.9)42 (50.6)34 (66.7)0.18
Family economic status, well-off & above, %105 (45.1)44 (53.0)18 (35.3)0.13
Marriage status, married, %201 (86.3)71 (85.5)41 (80.4)0.56
IBS disease course in yr16.0 (7.5)5.3 (7.0)6.0 (7.0)0.38
IBS type0.06
IBS-D, %95.796.486.3
IBS-C, %3.02.47.8
IBS-M, %1.31.25.9
Table 2 Characteristics of bowel symptoms in irritable bowel syndrome patients with abdominal pain alone, abdominal discomfort alone, and abdominal pain & discomfort
VariablePain group (n = 233)Discomfort group (n = 83)Pain & discomfort group (n = 51)P value
Location1, %0.213
Left lower quadrant67 (28.8)14 (16.9)12 (23.5)
Umbilical79 (33.9)27 (32.5)20 (39.2)
Lower abdomen65 (27.9)23 (27.7)15 (29.4)
Epigastric11 (4.7)2 (2.4)2 (3.9)
Whole abdomen12 (4.0)8 (9.6)5 (9.8)
Others24 (10.3)18 (21.7)7 (13.7)
Severity, %0.007
Mild21 (9.0)19 (22.9)6 (11.7)
Moderate160 (68.7)55 (66.3)37 (72.6)
Severe52 (22.3)9 (10.8)8 (15.7)
Frequency, %0.290
3 d/mo37 (15.9)11 (13.3)4 (7.84)
1 d/wk25 (10.7)5 (6.0)2 (3.9)
>1 d/wk108 (46.4)38 (45.8)27 (52.94)
Every day63 (27.0)29 (34.9)18 (35.3)
Ordinary pain/discomfort, %< 0.001
Pain alone84 (36.1)6 (7.2)6 (11.8)
Discomfort alone21 (9.0)43 (51.8)3 (5.9)
Pain & discomfort7 (3.0)2 (2.4)28 (54.9)
No pain or discomfort121 (51.9)32 (38.6)14 (27.4)
Defecation-related symptoms, %
Abdominal bloating93 (39.9)43 (51.8)35 (68.6)0.0013
Abdominal distension21 (9.0)13(15.7)12 (23.5)0.013
Urgency197 (84.6)80 (96.4)42 (82.4)0.012,4
Defecation straining70 (30.0)25 (30.1)23 (45.1)0.10
Sensation of anorectal obstruction62 (26.6)30 (36.1)19 (37.3)0.13
Anorectal pain28 (12.0)15 (18.1)17 (33.3)0.0013
Sensation of incomplete evacuation164 (70.4)74 (89.2)39 (76.5)0.0032
Passing mucus141 (60.5)66 (79.5)39 (76.5)0.0022
Table 3 Coexisting extraintestinal symptoms of irritable bowel syndrome patients with abdominal pain alone, abdominal discomfort alone, and abdominal pain & discomfort
VariablePain group (n = 233)Discomfort group (n = 83)Pain & discomfort group (n = 51)P value
GERD, %60 (25.8)14 (16.9)10 (19.6)0.20
Heartburn35 (15.0)6 (7.2)6 (11.8)0.18
Acid reflux44 (18.9)10 (12.1)5 (9.8)0.15
Food regurgitation14 (6.0)4 (4.8)3 (5.9)0.92
Retrosternal chest pain10 (4.3)3 (3.6)2 (3.9)0.96
Functional dyspepsia, %86 (36.9)23 (27.7)18 (35.3)0.32
Epigastric pain syndrome49 (21.0)6 (7.2)7 (13.7)0.012
Epigastric pain43 (18.5)5 (6.0)7 (13.7)0.022
Epigastric burning12 (5.2)2 (2.4)3 (5.9)0.54
Postprandial distress syndrome64 (27.5)22 (26.5)15 (29.4)0.94
Postprandial fullness57 (24.5)20 (24.1)9 (17.7)0.57
Early satiation14 (6.0)6 (7.2)9 (17.7)0.023
Somatic pain, %
Headache17 (45.9)37 (44.6)26 (51.0)0.76
Neck pain21 (9.0)7 (8.4)3 (5.9)0.77
Backache41 (17.6)8 (9.6)7 (13.7)0.21
Dyspareunia12 (5.2)6 (7.2)11 (21.6)< 0.0013,4
Menstrual pain130 (25.9)10 (37.0)11 (57.9)0.0163
Table 4 Comorbid anxiety and depression among irritable bowel syndrome patients with abdominal pain alone, abdominal discomfort alone, and abdominal pain & discomfort
VariablePain group (n = 233)Discomfort group (n = 83)Pain & discomfort group (n = 51)P value
HAMA score16.1 ± 7.315.5 ± 7.317.3 ± 7.40.36
Comorbid anxiety, %141 (60.5)49 (59.0)38 (74.5)0.14
Mild69 (29.6)25 (30.1)21 (41.2)0.26
Moderate-severe72 (30.9)24 (28.9)17 (33.3)0.86
HAMD score13.2 ± 6.212.3 ± 6.114.3 ± 5.50.18
Comorbid depression, %66 (28.3)22 (26.5)18 (35.3)0.53
Mild54 (23.2)20 (24.1)17 (33.3)0.31
Moderate-severe12 (5.2)2 (2.4)1 (2.0)0.40
Comorbid anxiety & depression, %62 (26.6)20 (24.1)18 (35.3)0.35
Table 5 Consultations and medications of irritable bowel syndrome patients with abdominal pain alone, abdominal discomfort alone, and abdominal pain & discomfort
VariablePain group (n = 233)Discomfort group (n = 83)Pain & discomfort group (n = 51)P value
In the whole disease course
Consultation times per year14.6 ± 6.75.7 ± 6.24.2 ± 4.10.54
Colonoscopies21.9 ± 1.41.5 ± 0.81.6 ± 0.90.22
In the last year
Consultation times14.0 ± 5.74.5 ± 4.54.9 ± 4.70.54
Medications, intermittent and long-term use, %164 (70.4)56 (67.5)43 (84.3)0.09
Antispasmodics use
Use rate29 (12.4)24 (28.9)12 (23.5)0.0023
Response rate22 (75.9)13 (54.2)10 (83.3)0.12
Overall satisfaction to medical care, %125 (53.7)39 (47.0)21 (41.2)0.21
Table 6 Risk factors for irritable bowel syndrome patients describing symptoms as abdominal pain alone, abdominal discomfort alone, and abdominal pain & discomfort
Partial regression coefficientStandard errorWald χ295%CIP value
Abdominal discomfort alone vs abdominal pain alone
Male sex0.6710.2915.2931.955 (1.104-3.462)0.021a
Severity (mild defecatory pain or discomfort)1.3910.5257.0184.020 (1.436-11.253)0.008a
Abdominal pain alone vs abdominal pain & discomfort
Abdominal bloating0.8050.3724.6922.238 (1.080-4.638)0.030a
Anorectal pain1.0910.4057.2722.979 (1.347-6.585)0.007a